Where does Cnrs-centre National DE LA Recherche Scientifique rank among US patent assignees?

According to USPTO PatentsView (2015–2025 granted utility patents), Cnrs-centre National DE LA Recherche Scientifique ranks #9,007 of 49,997 assignees by granted-patent volume, the same sort as the companies listing and top-holders ranking. See /methodology/#corpus-placement.

How many patents does Cnrs-centre National DE LA Recherche Scientifique hold?

Cnrs-centre National DE LA Recherche Scientifique holds 35 US utility patents granted between 2015 and 2025, spanning 47 technology areas.

What is Cnrs-centre National DE LA Recherche Scientifique's Innovation Score?

Cnrs-centre National DE LA Recherche Scientifique has an Innovation Score of 51.3 out of 100 (top 12% of the corpus). This composite metric weighs portfolio volume (40%), grant velocity (20%), technology breadth (25%), and claim depth (15%).

Is Cnrs-centre National DE LA Recherche Scientifique's patent grant rate increasing or decreasing?

Cnrs-centre National DE LA Recherche Scientifique's recent grant velocity is -64% compared to the prior five-year period (grant years, not application filing dates). Grant activity has slowed relative to earlier years.

What does claim depth mean for Cnrs-centre National DE LA Recherche Scientifique's patents?

Cnrs-centre National DE LA Recherche Scientifique's patents average 14.9 claims each. This is an aggregate descriptive count from the grant record; it does not establish claim scope, legal strength, enforceability, or design-around risk.

USPTO 2015–2025 USPTO PatentsView Foreign Corporation

Cnrs-centre National DE LA Recherche Scientifique

Q: What technology areas does Cnrs-centre National DE LA Recherche Scientifique focus on?

Cnrs-centre National DE LA Recherche Scientifique's top technology area is A61P (Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations) with 8 patents, ranking #2,286 of 6,058 assignees active in that subclass. Grants appear in 47 CPC subclasses total.

Q: How is the Cnrs-centre National DE LA Recherche Scientifique patent data sourced?

All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

USPTO PatentsView assignee record - 35 granted patents across 47 technology areas, recorded in grant years 2015–2025. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A61P (Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations).

Compiled by PlainPatent · May 15, 2026

RSS updates for this company

Explore the portfolio See the ranking

The verdict

According to USPTO PatentsView, Cnrs-centre ranks #9,007 of 49,997 tracked US assignees by granted-patent volume, with 35 patents across 47 technology areas.

#9,007
of 49,997 US assignees by volume: Top 12%
by Innovation Score (51.3/100): 14.9
avg claims per patent: -64%
grant velocity, last 5 yrs

USPTO PatentsView assignee plate

Corpus R9007 · Foreign Corporation #9,007 · 35 grants

GRANTS-SMALL · UPPER-Q · PHOTO-FINISH · CPC-WIDE · INNOV-PAR · CLAIMS-RICH · TYPE-FRNCORP · VEL-DROP · BOOK-FULL

GRANTS-SMALL 35 grants
UPPER-Q #9,007/49,997
PHOTO-FINISH Carlsmed
CPC-WIDE A61P · 47 areas
INNOV-PAR 51.3/100
CLAIMS-RICH 14.9 claims/avg
TYPE-FRNCORP Foreign Corp
VEL-DROP -64% vel
BOOK-FULL 10/10 fields

Nearest grant-volume peer: Carlsmed, Inc. (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

How Cnrs-centre’s 51.3 Innovation Score adds up

The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.

Volume 12.4 pts (24%) Velocity 5.7 pts (11%) Breadth 24.2 pts (47%) Claim depth 8.9 pts (17%)

Qualcomm Incorporated · highest

85
Cnrs-centre… · this assignee

51
Smartsens TECHNOLOGY… · near

51
Actym Therapeutics · near

51
Spatial Transcriptom… · near

51
Water Harvesting · near

51
3D Lighting… · lowest

7

What this shows Cnrs-centre's Innovation Score is 51.3/100 (top 12% of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Does more volume mean deeper claims for Cnrs-centre?

Each dot is one of Cnrs-centre’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Cnrs-centre’s own 14.9 claims/patent is ABOVE the 14.8 median for these volume peers. More thorough claims than most filers at this scale, not just more of them.

Cnrs-centre vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView.

Where Cnrs-centre's grants concentrate

Cnrs-centre National DE LA Recherche Scientifique is a focused PatentsView assignee: 47 CPC subclasses with 22.9% of grants classified under A61P (Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations). Peak complete grant year is 2015 (7 grants) versus a trough of 1 in 2021. By volume, Cnrs-centre sits between CFD Research Corporation and Children's Hospital Los Angeles.

Cnrs-centre's three-year grant acceleration

Cnrs-centre National DE LA Recherche Scientifique shows 6 grants in 2022–2024 against only 7 in 2019–2021. That prior window is too thin for a growth multiple (rename and spin-out assignees look artificially high when the baseline is near zero), so PlainPatent withholds a ranked acceleration claim here.

CFD Research

35
China Electric Po…

35
Cixi Huazhijie Pl…

35
CJ CGV

35
Code Systems

35
Corvia Medical

35
Carlsmed

35
Children's Hospit…

35
Cnrs-centre Natio… ◀

35

What this shows Cnrs-centre holds 35 patents at rank #9,001, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Companies ranked near Cnrs-centre

By rank, the assignees closest to #9,001 in granted patent volume.

Leaders in A61P (Specific Therapeutic Activity OF Chemical Compounds OR Me…)

Other assignees with the most granted patents in Cnrs-centre's primary technology class.

Assignees with similar portfolio profiles

Two PlainPatent-derived peer sets for Cnrs-centre, neither rank-band nor same-CPC leaders (those blocks stay above). In A61P (Specific Therapeutic Activity OF Chemical Compounds OR Me…), Cnrs-centre ranks #2,286 of 6,058 assignees by patent count in that subclass.

Similar innovation score

Nearest assignees by Innovation Score (51 here).

Smartsens TECHNOLOGY(HK) Co., Limited 51 Water Harvesting, Inc. 51 Actym Therapeutics, Inc. 51 Spatial Transcriptomics AB 51

Cnrs-centre's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

51 Top 12% higher than 88% of 49,997 US assignees

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

USPTO utility patent grants by year · 2015–2025

Grants by year

Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.

View data table

Cnrs-centre National DE LA Recherche Scientifique patent grants by year, 2015–2025
Year	Patents Granted	Share of Period
2015	7	20.0%
2016	4	11.4%
2017	5	14.3%
2018	5	14.3%
2019	4	11.4%
2020	2	5.7%
2021	1	2.9%
2022	1	2.9%
2023	2	5.7%
2024	3	8.6%
2025partial year	1	2.9%

Which technologies does Cnrs-centre National DE LA Recherche Scientifique patent most?

A61P - Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations 8

A61K - Preparations FOR Medical, Dental OR Toiletry Purposes 8

H01L - Semiconductor Devices NOT Covered BY Class H10 7

C12N - Microorganisms OR ENZYMES; Compositions THEREOF; Propagating, Preserving, OR Maintaining MICROORGANISMS; Mutation OR Genetic ENGINEERING; Culture Media 5

Y02E - Reduction OF Greenhouse GAS [GHG] Emissions, Related TO Energy Generation, Transmission OR Distribution 5

G01N - Investigating OR Analysing Materials BY Determining Their Chemical OR Physical Properties 5

Y02A - Technologies FOR Adaptation TO Climate Change 3

A61B - DIAGNOSIS; SURGERY; Identification 3

G02B - Optical Elements, Systems OR Apparatus 3

H10D - Inorganic Electric Semiconductor Devices 3

Y02P - Climate Change Mitigation Technologies IN THE Production OR Processing OF Goods 3

C25D - Processes FOR THE Electrolytic OR Electrophoretic Production OF COATINGS; ELECTROFORMING; Apparatus Therefor 3

C07K - Peptides 2

H01Q - Antennas, i.e. Radio Aerials 2

A61N - ELECTROTHERAPY; MAGNETOTHERAPY; Radiation THERAPY; Ultrasound Therapy 2

Top 15 of 47 technology areas

More on this record

Data Source

USPTO PatentsView, US granted patents 2015–2025

View all rankings → How is Innovation Score calculated?

What to do with this data

Cnrs-centre National DE LA Recherche Scientifique's patent record in context - here's where to go next.

Cnrs-centre National DE LA Recherche Scientifique's lead technology class is A61P (Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations), 22.9% of its portfolio - see every assignee active in that class. Explore A61P
Ranked #9,007 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
Compare Cnrs-centre National DE LA Recherche Scientifique against CFD Research Corporation, an assignee filing at a similar volume. Compare portfolios
Innovation Score of 51.3/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page

USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Compiled by PlainPatent, US Patent Intelligence Editorial Process · May 15, 2026

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.